Print page

The Role of Intellectual Property Rights in Biotechnology Innovation

Edited by David Castle, Professor of Public Administration and Vice President Research, University of Victoria, Canada
Intellectual property rights (IPRs), particularly patents, occupy a prominent position in innovation systems, but to what extent they support or hinder innovation is widely disputed. Through the lens of biotechnology, this book delves deeply into the main issues at the crossroads of innovation and IPRs to evaluate claims of the positive and negative impacts of IPRs on innovation.
Extent: 480 pp
Hardback Price: $213.00 Web: $191.70
Publication Date: 2009
ISBN: 978 1 84720 980 1
Availability: In Stock
Paperback Price: $66.00 Web: $52.80
Publication Date: 2011
ISBN: 978 1 84844 788 2
Availability: In Stock
$0.00

Buy the E-Book @ paperback price

Join our mailing list

  • Environment
  • Biotechnology
  • Innovation and Technology
  • Biotechnology
  • Law - Academic
  • Biotechnology and Pharmaceutical Law
  • Intellectual Property Law
Intellectual property rights (IPRs), particularly patents, occupy a prominent position in innovation systems, but to what extent they support or hinder innovation is widely disputed. Through the lens of biotechnology, this book delves deeply into the main issues at the crossroads of innovation and IPRs to evaluate claims of the positive and negative impacts of IPRs on innovation.

An international group of scholars from a range of disciplines – economic geography, health law, business, philosophy, history, public health, management – examine how IPRs actually operate in innovation systems, not just from the perspective of theory but grounded in their global, regional, national, current and historical contexts. In so doing, the contributors seek to uncover and move beyond deeply held assumptions about the role of IPRs in innovation systems.

Scholars and students interested in innovation, science and technology policy, intellectual property rights and technology transfer will find this volume of great interest. The findings will also be of value to decision makers in science and technology policy and managers of intellectual property in biotechnology and venture capital firms.
‘. . . recommended to anyone interested in the thrilling subject of the relationship of IPRs and innovation.’
– Ralf Uhrich, Journal of Intellectual Property

‘This is an outstanding piece of scholarship. It will serve as a powerful stimulant for new research in the field and as a reliable guide for practitioners.’
– Calestous Juma, Harvard University, US
Contributors: B. Asheim, C. Ayerbe, R.Y. Boadi, J.A. Bovenberg, T. Bubela, D. Castle, T. Caulfield, S. Chaturvedi, L.M. Cloutier, L.M. Cloutier, A.S. Daar, K.L. Durell, C.W. Francis, A.J. Glass, E.R. Gold, J.A. Holbrook, M. Ingham, I. Inkster, A.G. Isaac, F.S. Kieff, C. May, E. Métais, L. Mitkova, F.X. Nunez, S. Oriel, W.G. Park, T. Piper, S. Sirois, P.H. Sullivan, K. Sumikura, F. Valentin, C. Zeller
Contents:

Introduction
David Castle

PART I: INTELLECTUAL PROPERTY RIGHTS IN INNOVATION SYSTEMS
1. Introduction
David Castle

1. Are Intellectual Property Rights Quanta of Innovation?
J. Adam Holbrook

2. Intellectual Property Rights and Innovation Systems: Issues for Governance in a Global Context
Bjørn Asheim, Finn Valentin and Christian Zeller

3. Intellectual Property Rights Policy for Gene-Related Inventions – Toward Optimum Balance Between Public and Private Ownership
Koichi Sumikura

PART II: INTELLECTUAL PROPERTY MANAGEMENT IN BIOTECHNOLOGY
Introduction
Karen L. Durell

4. Fundamentals of Intellectual Property Management
Patrick H. Sullivan

5. Making a Return on R&D: A Business Perspective
Sharon Oriel

6. Looking Beyond the Firm: Intellectual Asset Management and Biotechnology
Karen L. Durell and E. Richard Gold

PART III: INTELLECTUAL PROPERTY RIGHTS IN RELATION TO OTHER MEASURES OF INNOVATION
Introduction
L. Martin Cloutier and David Castle

7. Increasing Internal Value from Patents: The Role of Organizational Arrangements
Marc Ingham, Cecile Ayerbe, Emmanuel Métais and Liliana Mitkova

8. Language System (LS) 3.0: An Agenda for a Model of Innovation Valuation
Clinton W. Francis

9. Measurement of Innovation and Intellectual Property Management: Challenging Processes
L. Martin Cloutier and Susanne Sirois

PART IV: BEYOND PATENT LENGTH
Introduction
Amy J. Glass and Fabricio X. Nunez

10. Open Development: Is the ‘Open Source’ Analogy Relevant to Biotechnology?
Alan G. Isaac and Walter G. Park

11. On the Border: Biotechnology, the Scope of Intellectual Property and the Dissemination of Scientific Benefits
Christopher May

12. On the Comparative Institutional Economics of Intellectual Property in Biotechnology
F. Scott Kieff

PART V: INNOVATION GOVERNANCE
Introduction
Tania Bubela

13. Accessibility of Biological Data: A Role for the European Database Right?
Jasper A. Bovenberg

14. Biotechnology Patents, Public Trust and Patent Pools: The Need for Governance?
Timothy Caulfield

15. Agricultural Biotechnology and Trends in the Intellectual Property Rights Regime: Emerging Challenges for Developing Countries
Sachin Chaturvedi


PART VI: NATIONAL, INTERNATIONAL AND HISTORICAL COMPARISONS
Introduction
Abdallah S. Daar and David Castle

16. The Role of Intellectual Property Rights in Biotechnology Innovation: National and International Comparisons
Richard Y. Boadi

17. Intellectual Property, Information and Divergences in Economic Development – Institutional Patterns and Outcomes circa 1421–2000
Ian Inkster

18. Watch What You Export: The History of Medical Exceptions from Patentability
Tina Piper

Index